Global Liver Institute

Is Your Liver Healthy?

GLOBAL LIVER INSTITUTE

Is Your Liver Healthy?

At Global Liver Institute, we believe it all starts with a patient.

Did you know that an estimated 1.5 billion people around the world are affected by a liver condition?

This fact might lead you to the core question of this show: Is Your Liver Healthy? In monthly conversations, our host Jeff McIntyre explores a new part of the answer to this question by sitting down with the people who know the most about liver health and related conditions – whether that’s through their medical research, training and practice, personal experiences, or professional work. Join each month to learn what affects liver health, how liver disease impacts lives, and the actions we can all take to improve liver health for ourselves and our communities.

“Is Your Liver Healthy?” is produced by Global Liver Institute (GLI). It was born out of the interview show GLI LIVE, which GLI started in March 2020 as a COVID-19 response program for liver patients.

Check out the show on YouTube, Spotify, Apple Podcasts, Amazon Music, Audible, or wherever you get your podcasts!

See All Episodes of Is Your Liver Healthy? on

GLP-1s, or glucagon-like peptide-1 receptor agonists, are a class of medications used to treat type 2 diabetes, obesity, kidney disease, and other conditions. These drugs mimic GLP-1, a hormone that affects insulin release, slows stomach emptying, and affects satiety. Early studies suggest that GLP-1 drugs can benefit liver health as well. Explore the basics and what liver patients should know about GLP-1s with this month's guests:

Joe Naglowski, President & CEO, Obesity Action Coalition (https://www.obesityaction.org/)
Dr. Janese Laster, Gastroenterologist & founder of Gut Theory Total Digestive Care (https://www.guttheoryhealth.com/)

This video is private.

YouTube Video UExqMWFXM3l6RnhLTzFEcmxPMDJMSHlpRUxfUWRQcjhLUy41MjE1MkI0OTQ2QzJGNzNG

IYLH S1E3

Patients with rare (liver) diseases need access to clinical trials, but those in rural areas lack access due to structural and geographic barriers – which affects opportunities and generalizability of data for everyone.

This Rare Liver Diseases Month, GLI is focusing on the issues affecting Rare & Rural communities. In this episode, hear from our guests on the challenges for rare & rural liver disease patients in their communities.

Learn about our guests & their upcoming events:
Dr. Harsha Rajasimha - IndoUSRare (https://www.indousrare.org/)
Dr. Cecilia Dueñas - PBC Research Foundation (https://www.pbcresearchfoundation.org/)
Teresa Davidson - Mid South Liver Alliance (https://midsouthliveralliance.org/)
Kristin Hatcher - Global Liver Institute (https://globalliver.org/rare-liver-diseases-month/)

Learn more about Global Liver Institute on our website: https://globalliver.org.

Patients with rare (liver) diseases need access to clinical trials, but those in rural areas lack access due to structural and geographic barriers – which affects opportunities and generalizability of data for everyone.

This Rare Liver Diseases Month, GLI is focusing on the issues affecting Rare & Rural communities. In this episode, hear from our guests on the challenges for rare & rural liver disease patients in their communities.

Learn about our guests & their upcoming events:
Dr. Harsha Rajasimha - IndoUSRare (https://www.indousrare.org/)
Dr. Cecilia Dueñas - PBC Research Foundation (https://www.pbcresearchfoundation.org/)
Teresa Davidson - Mid South Liver Alliance (https://midsouthliveralliance.org/)
Kristin Hatcher - Global Liver Institute (https://globalliver.org/rare-liver-diseases-month/)

Learn more about Global Liver Institute on our website: https://globalliver.org.

YouTube Video UExqMWFXM3l6RnhLTzFEcmxPMDJMSHlpRUxfUWRQcjhLUy4wMTcyMDhGQUE4NTIzM0Y5

Rare & Rural Access to Care and Research (Is Your Liver Healthy? Episode 2)

Liver diseases pose a serious threat to communities all over the world. The scientific and medical community have many of the tools to treat and prevent liver disease, but a political will to operationalize programs to prevent, diagnose, and treat these diseases is necessary to turn the tide.

In this episode of "Is Your Liver Healthy?" guests from around the world join our host, Jeff McIntyre, to discuss the recently released 3rd edition of the Global State of Liver Health report (https://globalliver.org/liver-health-is-public-health/resources/) and talk about what's next in their communities to improve liver health.

Guests this episode:
José Willemse, Former Executive Director & Patient Advocate, Dutch Liver Patients Association
Dr. Aleksander Krag, Secretary General of the European Association for the Study of the Liver & Professor/Department Chair in Gastroenterology & Hepatology at Odense University Hospital (Denmark)
Dr. Mahmoud Desoky, Consultant Gastroenterologyst in Saudi Arabia
Dr. Viet Hang Dao, Vice General Secretary, Vietnam Association of Gastroenterology
Dr. Laz Ude Eze, Public Health Physician & Founder of TalkHealth9ja (Nigeria)
Dr. Manal El-Sayed, Pediatrician & Researcher, Ain Shams University (Egypt)

Liver diseases pose a serious threat to communities all over the world. The scientific and medical community have many of the tools to treat and prevent liver disease, but a political will to operationalize programs to prevent, diagnose, and treat these diseases is necessary to turn the tide.

In this episode of "Is Your Liver Healthy?" guests from around the world join our host, Jeff McIntyre, to discuss the recently released 3rd edition of the Global State of Liver Health report (https://globalliver.org/liver-health-is-public-health/resources/) and talk about what's next in their communities to improve liver health.

Guests this episode:
José Willemse, Former Executive Director & Patient Advocate, Dutch Liver Patients Association
Dr. Aleksander Krag, Secretary General of the European Association for the Study of the Liver & Professor/Department Chair in Gastroenterology & Hepatology at Odense University Hospital (Denmark)
Dr. Mahmoud Desoky, Consultant Gastroenterologyst in Saudi Arabia
Dr. Viet Hang Dao, Vice General Secretary, Vietnam Association of Gastroenterology
Dr. Laz Ude Eze, Public Health Physician & Founder of TalkHealth9ja (Nigeria)
Dr. Manal El-Sayed, Pediatrician & Researcher, Ain Shams University (Egypt)

YouTube Video UExqMWFXM3l6RnhLTzFEcmxPMDJMSHlpRUxfUWRQcjhLUy4yODlGNEE0NkRGMEEzMEQy

The Global State of Liver Health (Is Your Liver Healthy? Episode 1)

In "Is Your Liver Healthy?" the team at Global Liver Institute (GLI) bring stories about the factors and forces that affect liver health to liver patients and their loved ones.

In this preview episode, our host Jeff McIntyre invites staff from GLI, who will appear on future episodes, to introduce themselves and cast a vision for liver health in 2025.

Learn more about GLI and our work at globalliver.org

In "Is Your Liver Healthy?" the team at Global Liver Institute (GLI) bring stories about the factors and forces that affect liver health to liver patients and their loved ones.

In this preview episode, our host Jeff McIntyre invites staff from GLI, who will appear on future episodes, to introduce themselves and cast a vision for liver health in 2025.

Learn more about GLI and our work at globalliver.org

YouTube Video UExqMWFXM3l6RnhLTzFEcmxPMDJMSHlpRUxfUWRQcjhLUy41NkI0NEY2RDEwNTU3Q0M2

*New Show* Welcome to "Is Your Liver Healthy?"